Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties

作者: Grant R. Campbell , David Senkaali , Jennifer Watkins , Didier Esquieu , Sandrine Opi

DOI: 10.1016/J.VACCINE.2007.09.070

关键词:

摘要: Humoral responses against extra-cellular HIV-1 Tat may be beneficial as has been implicated in the viral pathogenesis associated with disease progression. We determined levels of anti-Tat IgG sera seropositive individuals from Rural Clinical Cohort Uganda using nine different proteins representative major subtypes presently accounting for 97% infections worldwide. observed presence able to react various tested, although none cross-reacted all variants. show that 46.25% patients were recognise at least one variant 1:1000 dilution. also C terminus is most variable region and an important epitope might explain limitation cross-recognition antibodies regarding This study shows can tolerate mutations without modification its primary function but changes immunogenic properties. These findings should considered when designing Tat-based vaccines.

参考文章(41)
Daniel Zagury, Bernard Bizzini, Anne Sill, Alessandro Gringeri, Jean-François Zagury, William Blattner, Abderrahim Lachgar, Hélène Le Buanec, Robert C. Gallo, Houria Hendel, Miguel Carcagno, Marcelo Criscuolo, Arsène Burny, Jay Rappaport, Malcolm Richardson, Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. Journal of Human Virology. ,vol. 1, pp. 282- 292 ,(1998)
B Ensoli, L Buonaguro, G Barillari, V Fiorelli, R Gendelman, R A Morgan, P Wingfield, R C Gallo, Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology. ,vol. 67, pp. 277- 287 ,(1993) , 10.1128/JVI.67.1.277-287.1993
W. Curtis Johnson, Circular Dichroism and Its Empirical Application to Biopolymers Methods of Biochemical Analysis. ,vol. 31, pp. 61- 163 ,(1985) , 10.1002/9780470110522.CH2
F Gao, S G Morrison, D L Robertson, C L Thornton, S Craig, G Karlsson, J Sodroski, M Morgado, B Galvao-Castro, H von Briesen, S Beddows, J Weber, P M Sharp, G M Shaw, B H Hahn, Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. Journal of Virology. ,vol. 70, pp. 1651- 1667 ,(1996) , 10.1128/JVI.70.3.1651-1667.1996
C A van Baalen, R C Huisman, M R Klein, R A Gruters, F Miedema, A M Geretti, A D Osterhaus, O Pontesilli, F de Wolf, Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS Journal of General Virology. ,vol. 78, pp. 1913- 1918 ,(1997) , 10.1099/0022-1317-78-8-1913
F Clavel, P Charneau, Fusion from without directed by human immunodeficiency virus particles. Journal of Virology. ,vol. 68, pp. 1179- 1185 ,(1994) , 10.1128/JVI.68.2.1179-1185.1994
Kuan-Teh Jeang, Hua Xiao, Elizabeth A. Rich, MULTIFACETED ACTIVITIES OF THE HIV-1 TRANSACTIVATOR OF TRANSCRIPTION, TAT Journal of Biological Chemistry. ,vol. 274, pp. 28837- 28840 ,(1999) , 10.1074/JBC.274.41.28837
M.C. Re, M. Vignoli, G. Furlini, D. Gibellini, V. Colangeli, F. Vitone, M. La Placa, Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. Journal of Clinical Virology. ,vol. 21, pp. 81- 89 ,(2001) , 10.1016/S1386-6532(00)00189-X
Catherine Grégoire, Jean-Marie Péloponèse, Didier Esquieu, Sandrine Opi, Grant Campbell, Murielle Solomiac, Evelyne Lebrun, Jacques Lebreton, Erwann P. Loret, Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers. ,vol. 62, pp. 324- 335 ,(2001) , 10.1002/BIP.10000